Mini Review The Promising Role of Flavonoids in Chronic Obstructive Pulmonary Disease

Background : Flavonoid-rich foods are beneficially associated with enhancing pulmonary function; however, the protective effects of flavonoids may have an impact on COPD through anti-inflammatory mechanisms. Chronic obstructive pulmonary disease (COPD) is a prevalent lung disease with a high death rate and multiple health problems. Recently, up to 7000 flavonoids have been identified as having anticancer, antioxidant, and anti-inflammatory properties. Various mechanisms of action of flavonoids have been implicated. Aim : This review aims to identify and appraise various flavonoids used in managing COPD and reveal their mechanisms. Methods : We searched the Web of Sciences, Google Scholar, PubMed, Scopus, and EMBASE databases from December 1975 to February 2022 by using the relevant keywords for this narrative review. Results : Many flavonoids were found to be effective in the management of COPD, such as liquiritin apioside, quercetin, baicalin, naringin, hesperidin, silymarin, and casticin. The proposed mechanisms for these flavonoids could either be attributed to antioxidant or anti-inflammatory activity. Conclusion : Flavonoids could be a promising alternative to be developed and tested for the treatment of COPD in clinical settings.

[1]  M. Kamal,et al.  Therapeutic Role of Flavonoids in Lung Inflammatory Disorders , 2022, Phytomedicine Plus.

[2]  Zheng Li,et al.  Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease , 2020, Evidence-based complementary and alternative medicine : eCAM.

[3]  Rongchang Chen,et al.  Casticin Improves Respiratory Dysfunction and Attenuates Oxidative Stress and Inflammation via Inhibition of NF-ĸB in a Chronic Obstructive Pulmonary Disease Model of Chronic Cigarette Smoke-Exposed Rats , 2020, Drug design, development and therapy.

[4]  Haiyan Xing,et al.  Function of hesperidin alleviating inflammation and oxidative stress responses in COPD mice might be related to SIRT1/PGC-1α/NF-κB signaling axis , 2020, Journal of receptor and signal transduction research.

[5]  Meilan K. Han,et al.  Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease , 2020, BMJ Open Respiratory Research.

[6]  J. Hogg,et al.  Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. , 2019, The New England journal of medicine.

[7]  Hongying Zhang,et al.  Baicalin Exerts Anti-Airway Inflammation and Anti-Remodelling Effects in Severe Stage Rat Model of Chronic Obstructive Pulmonary Disease , 2018, Evidence-based complementary and alternative medicine : eCAM.

[8]  P. Barnes,et al.  Quercetin restores corticosteroid sensitivity in cells from patients with chronic obstructive pulmonary disease , 2017, Experimental lung research.

[9]  Ming-hong Zhao,et al.  Naringenin ameliorates LPS-induced acute lung injury through its anti-oxidative and anti-inflammatory activity and by inhibition of the PI3K/AKT pathway. , 2017, Experimental and therapeutic medicine.

[10]  Jovilė Raudoniūtė,et al.  Novel aspects of pathogenesis and regeneration mechanisms in COPD , 2015, International journal of chronic obstructive pulmonary disease.

[11]  Fuqiang Wen,et al.  Silymarin Attenuates Airway Inflammation Induced by Cigarette Smoke in Mice , 2015, Inflammation.

[12]  B. Fischer,et al.  COPD: balancing oxidants and antioxidants , 2015, International journal of chronic obstructive pulmonary disease.

[13]  Y. Tesfaigzi,et al.  Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung. , 2014, American journal of respiratory cell and molecular biology.

[14]  M. Martins,et al.  Structure-Activity Association of Flavonoids in Lung Diseases , 2014, Molecules.

[15]  P. Poole,et al.  Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. , 2013, The Cochrane database of systematic reviews.

[16]  P. Kirkham,et al.  Oxidative stress in COPD. , 2013, Chest.

[17]  Yan Guan,et al.  Protective effects of liquiritin apioside on cigarette smoke‐induced lung epithelial cell injury , 2012, Fundamental & clinical pharmacology.

[18]  Q. Luo,et al.  Baicalin is anti-inflammatory in cigarette smoke-induced inflammatory models in vivo and in vitro: A possible role for HDAC2 activity. , 2012, International immunopharmacology.

[19]  T. Tsuji,et al.  DNA damage as a molecular link in the pathogenesis of COPD in smokers , 2012, European Respiratory Journal.

[20]  P. Moon,et al.  Naringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cells. , 2011, European journal of pharmacology.

[21]  Baojun Liu,et al.  Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models. , 2010, Pulmonary pharmacology & therapeutics.

[22]  P. Girodet,et al.  Epidemiology of COPD , 2009, European Respiratory Review.

[23]  K. O'Byrne,et al.  Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy , 2009, Journal of cellular and molecular medicine.

[24]  Kenneth S. Yew,et al.  Diagnosis of chronic obstructive pulmonary disease. , 2008, American family physician.

[25]  B. O'connor,et al.  Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. , 2005, Journal of immunology.

[26]  G. Kidder,et al.  Oxygenation of frog gastric mucosa in vitro. , 1975, The American journal of physiology.

[27]  L. Milella,et al.  Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. , 2018, Biotechnology advances.